Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 4372289)

Published in PLoS One on March 24, 2015

Authors

Jiang-Wei Sun1, Long-Gang Zhao1, Yang Yang1, Xiao Ma1, Ying-Ying Wang1, Yong-Bing Xiang1

Author Affiliations

1: State Key Laboratory of Oncogene and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Articles cited by this

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16

Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59

Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer (2004) 16.69

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00

Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet (2014) 6.61

Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials (2006) 6.11

Overweight, obesity, and cancer risk. Lancet Oncol (2002) 4.44

Dose-response analyses using restricted cubic spline functions in public health research. Stat Med (2010) 3.58

Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health (1987) 3.44

Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol (2011) 3.16

Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med (2010) 3.07

The predictive validity of body mass index based on self-reported weight and height. Int J Obes (1989) 2.65

Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control (2006) 2.64

Obesity and cancer risk among white and black United States veterans. Cancer Causes Control (2004) 2.36

Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer (2005) 2.33

Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol (2006) 2.13

Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J (1975) 2.12

Body mass index and cancer risk in Korean men and women. Int J Cancer (2008) 1.89

Weight control and physical activity in cancer prevention. Obes Rev (2002) 1.79

Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer (2008) 1.79

Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75

Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol (2011) 1.71

Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer (2002) 1.51

The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer (2005) 1.24

Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev (2013) 1.23

Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis (2009) 1.21

Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer (2008) 1.20

Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev (2008) 1.15

Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ (2013) 1.15

Bladder-cancer incidence in relation to vegetable and fruit consumption: a prospective study of atomic-bomb survivors. Int J Cancer (2000) 1.10

Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol (2003) 1.10

Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev (2003) 1.10

Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer (2006) 1.09

Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer (2007) 1.06

Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control (2005) 1.04

Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol (2002) 0.99

Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control (2010) 0.99

Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol (2014) 0.98

Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer (2011) 0.96

Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer (2014) 0.94

Obesity and risk of bladder cancer: a meta-analysis of cohort studies. Asian Pac J Cancer Prev (2013) 0.94

Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers (2014) 0.91

Cause-effect? Understanding the risk factors associated with bladder cancer. Expert Rev Anticancer Ther (2012) 0.82

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol Res (1993) 0.81